1969

1969

1968-1970

Suzuki and Takaku first described moyamoya and its staging in 1969 1).


Lyodura was a medical product used in neurosurgery that has been shown to transmit Creutzfeldt Jakob disease, a degenerative neurological disorder that is incurable, from affected donor cadavers to surgical recipients. Lyodura was introduced in 1969 as a product of B. Braun Melsungen AG, a leading hospital supply company based in Germany.


1)
Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969 Mar;20(3):288-99. doi: 10.1001/archneur.1969.00480090076012. PMID: 5775283.
  • 1969.txt
  • Last modified: 2021/03/30 11:36
  • by administrador